NIDDK-sponsored Chronic Prostatitis Collaborative Research Network (CPCRN) 5-year data and treatment guidelines for bacterial prostatitis

International Journal of Antimicrobial Agents

Volumn 24, Issue SUPPL. 1, 2004, Pages 49-52

  Schaeffer, Anthony J ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

Chronic pelvic pain; Prostatitis; Treatment guidelines

Indexed keywords

CIPROFLOXACIN; IMMUNOSUPPRESSIVE AGENT; PENICILLIN DERIVATIVE; PLACEBO; QUINOLINE DERIVED ANTIINFECTIVE AGENT; TAMSULOSIN;

ANTIMICROBIAL THERAPY; CHRONIC PROSTATITIS; CLINICAL FEATURE; CLINICAL RESEARCH; COHORT ANALYSIS; CONFERENCE PAPER; DIAGNOSTIC APPROACH ROUTE; DRUG ABSORPTION; HEALTH PROMOTION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INFLAMMATORY INFILTRATE; LOW DRUG DOSE; MEDICAL SOCIETY; PELVIS PAIN SYNDROME; PRACTICE GUIDELINE; PRIORITY JOURNAL;

EID: 4444257422     PISSN: 09248579     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijantimicag.2004.02.009     Document Type: Conference Paper

References (11)

1. Mehik A., Hellstrom P., Lukkarinen O., et al. Epidemiology of prostatitis in Finnish men: a population-based cross-sectional study. Br J Urol Int. 86:2000;443-448
2. Stamey T. Urinary tract infections in males. In: Stamey T, editor. Pathogenesis and treatment of urinary tract infections. Baltimore: Williams and Wilkins; 1980. p. 342-429.
3. Koch H. Office visits for male genitourinary conditions. Washington DC: Public Health Service, Office for Health Research, Statistics and Technology; 1980.
4. Litwin M.S., McNaughton-Collins M., Fowler F.J. Jr., et al. The National Institutes of Health Chronic Prostatitis Symptom Index: development and validation of a new outcome measure. J. Urol. 162:1999;369-375
5. Schaeffer A.J., Landis J.R., Knauss J.S., et al. Demographic and clinical characteristics of men with chronic prostatitis: the NIH Chronic Prostatitis Cohort (CPC) Study. J Urol. 168:2002;593-598
6. Schaeffer A.J., Knauss J.S., Landis J.R., et al. Leukocyte and bacterial counts do not correlate with severity of symptoms in men with chronic prostatitis: the NIH Chronic Prostatitis Cohort (CPC) Study. J Urol. 168:2002;1048-1053
7. Calhoun EA, McNaughton Collins M, Pontari MA. The economic impact of chronic prostatitis. Arch Int Med 2003, in press.
8. Nadler R.B., Koch A.E., Calhoun E.A., et al. IL-1β and TNF-α in prostatic secretions are key indicators in the evaluation of men with chronic prostatitis. J Urol. 164:2000;214-218
9. Hochreiter W.W., Nadler R.B., Koch A.E., et al. Evaluation of the cytokines interleukin-8 and epithelial neutrophil activating peptide-78 as indicators of inflammation in prostatic secretions. Urology. 56:2000;1025-1029
10. Clemens J.Q., Nadler R.B., Schaeffer A.J., Belani J., Albaugh J., Bushman W. Biofeedback, pelvic floor re-education, and bladder training for male chronic pelvic pain syndrome. Urology. 56:2000;951-955
11. Naber KG. Antibiotic treatment of chronic bacterial prostatitis. In: Nickel JC, editor. Textbook of prostatitis. Oxford, UK: Isis Medical Media; 1999. p. 285-92.